skip to content
Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017. Preview this item
ClosePreview this item
Checking...

Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.

Author: United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Health Care, Benefits, and Administrative Rules,
Publisher: Washington : U.S. Government Publishing Office, 2017.
Edition/Format:   Book   Microform : National government publication : Microfiche : EnglishView all editions and formats
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Legislative hearings
Additional Physical Format: Print version:
United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Health Care, Benefits, and Administrative Rules.
Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain
(DLC) 2017415181
(OCoLC)1013554615
Online version:
United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Health Care, Benefits, and Administrative Rules.
Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain
(OCoLC)1013542208
Material Type: Government publication, National government publication
Document Type: Book
All Authors / Contributors: United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Health Care, Benefits, and Administrative Rules,
OCLC Number: 1042815421
Notes: "Serial no. 115-33."
Shipping list no.: 2018-0099-M.
Reproduction Notes: Microfiche. [Washington, D.C.] : U.S. Government Printing Office, [2018] 1 microfiche : negative.
Description: iii, 54 pages ; 24 cm

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/1042815421> # Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
    a schema:CreativeWork, bgn:Microform, schema:Book ;
    library:oclcnum "1042815421" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/dcu> ;
    schema:about <http://id.loc.gov/authorities/classification/KF27> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/4649842184#Topic/consumer_protection> ; # Consumer protection
    schema:about <http://experiment.worldcat.org/entity/work/data/4649842184#Topic/generic_drugs_development_united_states> ; # Generic drugs--Development--United States
    schema:about <http://experiment.worldcat.org/entity/work/data/4649842184#Topic/competition_united_states> ; # Competition--United States
    schema:about <http://experiment.worldcat.org/entity/work/data/4649842184#Place/united_states> ; # United States.
    schema:about <http://experiment.worldcat.org/entity/work/data/4649842184#Topic/pharmaceutical_policy_united_states> ; # Pharmaceutical policy--United States
    schema:about <http://experiment.worldcat.org/entity/work/data/4649842184#Topic/prescription_pricing_united_states> ; # Prescription pricing--United States
    schema:about <http://experiment.worldcat.org/entity/work/data/4649842184#Topic/pharmaceutical_industry_corrupt_practices_united_states> ; # Pharmaceutical industry--Corrupt practices--United States
    schema:about <http://experiment.worldcat.org/entity/work/data/4649842184#Topic/consumer_protection_united_states> ; # Consumer protection--United States
    schema:about <http://experiment.worldcat.org/entity/work/data/4649842184#Topic/prescription_pricing> ; # Prescription pricing
    schema:about <http://experiment.worldcat.org/entity/work/data/4649842184#Topic/competition> ; # Competition
    schema:about <http://experiment.worldcat.org/entity/work/data/4649842184#Topic/pharmaceutical_industry_corrupt_practices> ; # Pharmaceutical industry--Corrupt practices
    schema:about <http://experiment.worldcat.org/entity/work/data/4649842184#Topic/pharmaceutical_policy> ; # Pharmaceutical policy
    schema:author <http://experiment.worldcat.org/entity/work/data/4649842184#Organization/united_states_congress_house_committee_on_oversight_and_government_reform_subcommittee_on_health_care_benefits_and_administrative_rules> ; # United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Health Care, Benefits, and Administrative Rules,
    schema:datePublished "2017" ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/4649842184> ;
    schema:genre "National government publication"@en ;
    schema:genre "Government publication"@en ;
    schema:genre "Legislative hearings"@en ;
    schema:inLanguage "en" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/1013554615> ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/1013542208> ;
    schema:name "Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017."@en ;
    schema:productID "1042815421" ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/1042815421> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/4649842184#Organization/united_states_congress_house_committee_on_oversight_and_government_reform_subcommittee_on_health_care_benefits_and_administrative_rules> # United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Health Care, Benefits, and Administrative Rules,
    a schema:Organization ;
    schema:name "United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Health Care, Benefits, and Administrative Rules," ;
    .

<http://experiment.worldcat.org/entity/work/data/4649842184#Place/united_states> # United States.
    a schema:Place ;
    schema:name "United States." ;
    .

<http://experiment.worldcat.org/entity/work/data/4649842184#Topic/competition_united_states> # Competition--United States
    a schema:Intangible ;
    schema:name "Competition--United States"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4649842184#Topic/consumer_protection> # Consumer protection
    a schema:Intangible ;
    schema:name "Consumer protection"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4649842184#Topic/consumer_protection_united_states> # Consumer protection--United States
    a schema:Intangible ;
    schema:name "Consumer protection--United States"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4649842184#Topic/generic_drugs_development_united_states> # Generic drugs--Development--United States
    a schema:Intangible ;
    schema:name "Generic drugs--Development--United States"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4649842184#Topic/pharmaceutical_industry_corrupt_practices> # Pharmaceutical industry--Corrupt practices
    a schema:Intangible ;
    schema:name "Pharmaceutical industry--Corrupt practices"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4649842184#Topic/pharmaceutical_industry_corrupt_practices_united_states> # Pharmaceutical industry--Corrupt practices--United States
    a schema:Intangible ;
    schema:name "Pharmaceutical industry--Corrupt practices--United States"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4649842184#Topic/pharmaceutical_policy> # Pharmaceutical policy
    a schema:Intangible ;
    schema:name "Pharmaceutical policy"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4649842184#Topic/pharmaceutical_policy_united_states> # Pharmaceutical policy--United States
    a schema:Intangible ;
    schema:name "Pharmaceutical policy--United States"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4649842184#Topic/prescription_pricing> # Prescription pricing
    a schema:Intangible ;
    schema:name "Prescription pricing"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4649842184#Topic/prescription_pricing_united_states> # Prescription pricing--United States
    a schema:Intangible ;
    schema:name "Prescription pricing--United States"@en ;
    .

<http://www.worldcat.org/oclc/1013542208>
    a schema:CreativeWork ;
    rdfs:label "Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain" ;
    schema:description "Online version:" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/1042815421> ; # Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
    .

<http://www.worldcat.org/oclc/1013554615>
    a schema:CreativeWork ;
    rdfs:label "Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain" ;
    schema:description "Print version:" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/1042815421> ; # Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
    .

<http://www.worldcat.org/title/-/oclc/1042815421>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
    schema:about <http://www.worldcat.org/oclc/1042815421> ; # Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
    schema:dateModified "2019-12-07" ;
    void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.